Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
about
No quiet surrender: molecular guardians in multiple sclerosis brainA New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation.Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathyTherapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.Novel roles for α-crystallins in retinal function and disease.Alpha crystallins in the retinal pigment epithelium and implications for the pathogenesis and treatment of age-related macular degenerationChaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis.Crystallins and neuroinflammation: The glial side of the story.Chaperone peptides of α-crystallin inhibit epithelial cell apoptosis, protein insolubilization, and opacification in experimental cataractsPromotion of axon regeneration and inhibition of astrocyte activation by alpha A-crystallin on crushed optic nerve.A Journey in Science: The Privilege of Exploring the Brain and the Immune System.Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.Impact of diabetes on alpha-crystallins and other heat shock proteins in the eye.Janus faces of amyloid proteins in neuroinflammation.Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses.Therapeutic potential of α-crystallin.Identification of highly connected hub genes in the protective response program of human macrophages and microglia activated by alpha B-crystallin.Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.Heat shock protein-70 and hypoxia inducible factor-1α in type 2 diabetes mellitus patients complicated with retinopathy.Piet Mondrian's trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011.A specific phosphorylation regulates the protective role of αA-crystallin in diabetes.
P2860
Q28084633-E4DAB2AE-8288-4A0A-9A1D-752D0F3C241EQ28730158-649E3A94-3657-448E-B073-0E4E009E103EQ34336783-B5DC8825-9FFF-40CC-A78D-07CA99B24DB4Q34866847-690CA178-EE5E-492D-B740-04DC2B1B295CQ34905119-9717544B-C079-438D-A8E5-15711D5E36CDQ35164861-6D309B0B-C6E2-491B-92E0-5D58EC02575AQ35278528-67BA56ED-11F9-45DF-80F0-76A523780979Q35849942-86473CB7-CE21-4FF8-A0D1-CA13666D182AQ35879972-DB9ECB30-2F77-40E9-8F6A-3DDAC3677BD8Q36319594-6987A311-59BD-4060-8EAE-671B108EB9E6Q36326891-3FEC9D9A-4A96-45E8-9372-137EE287301CQ36332934-41C3D995-E23F-4086-A7AD-082B645BBDEEQ36345592-15C5092F-F12E-4B05-AF3E-61F44A7ED3E9Q36812475-70FB97FC-4E03-4EBC-BC3C-2D8B35AEA4BAQ37110854-48A54CAB-F32F-4925-82CC-28DDDB943DEFQ37217037-8A6BA3C0-3D52-4F8A-9DF6-AFC44531BBC0Q37372314-53389BAC-6B77-4F6A-9E14-62122E4C3CBBQ38069581-09E27B17-39CD-43BC-A55B-910BA1033E26Q38202911-FE6C25FE-8985-47F2-A0AA-821073FACAF7Q38359329-56575680-B621-4B14-9764-973FF1E99B56Q38404383-B0955EA7-82D6-410C-8EF3-9A9DABFBD2E5Q39034589-4121CBF0-246E-48E3-A3EC-464A4D620B92Q40313198-EAB69204-F527-4BCD-85D7-038C58E74925Q44587763-171F8621-2D62-4E76-9EC0-12FDBA2B0EF8Q46527092-6A8E3564-FC6B-4F7F-902D-7A9E10D95A18Q48285545-0D50804A-CF89-4253-BBAB-5E644CE17A04Q50146188-E4A6FA3F-8D96-406E-BD9E-EB972E825419
P2860
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
@ast
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
@en
type
label
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
@ast
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
@en
prefLabel
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
@ast
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
@en
P2093
P2860
P356
P1433
P1476
Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.
@en
P2093
L Steinman
S Pangratz-Fuehrer
S S Ousman
P2860
P2888
P304
P356
10.1038/EYE.2011.42
P577
2011-04-08T00:00:00Z